Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 9.00
Ask: 9.50
Change: -0.65 (-6.74%)
Spread: 0.50 (5.556%)
Open: 9.50
High: 10.20
Low: 9.00
Prev. Close: 9.00
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

Wed, 02nd Jun 2021 16:02

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Sancus Lending Group Ltd - Guernsey-based alternative property finance - Andy Whelan resigns as chief executive officer, leaving on June 30, when he will be replaced by Rory Mepham as interim CEO. Mepham currently is in charge of funding and origination, having joined the company in January. Dan Walker, who currently is chief operating officer and managing director of Sancus UK, will become deputy CEO. Walker joined the company in 2018 from Lloyds Banking Group PLC, where he was director of Strategic Transactions. The changes follow refinancing and restructuring at Sancus, including renaming itself from GLI Finance Ltd, which was approved by shareholders earlier this month. This is to reflect its focus on the property bridging and development finance activities of the Sancus subsidiary.

----------

Cambridge Cognition Holdings PLC - Cambridge, England-based neuroscience technology - Adds Chief Financial Officer Mick Holton to board as executive director, effective immediately. Holton joined Cambridge Cognition in January from Biome Technologies PLC, where he was interim CFO. He previously worked for what is now Walgreens Boots Alliance Inc.

----------

Dispersion Holdings PLC - investor in decentralised finance, which uses blockchain and cryptocurrencies to remove financial intermediaries from transactions - Adds CFO Nick Lyth to board, effective immediately. Dispersion listed on Aquis Stock Exchange in late April, raising GBP9 million in its initial public offering and GBP2.2 million in pre-IPO fundraisings.

----------

e-Therapeutics PLC - Oxford, England-based drug discovery - Hires Alison Gallafent as head of Intellectual Property. Gallefent was head of IP at fellow AIM listing Silence Therapeutics PLC and also worked at Merck & Co Inc and Glaxo Wellcome.

----------

SDX Energy PLC - gas production in Egypt and exploration & development in Morocco - Amr Al Menhali will retire as director at annual general meeting on June 25, having left shareholder Waha Capital. Al Manhali had joined the SDX board back in September 2019, having been named CEO of Waha, which is SDX's largest shareholder, with a 19.5% stake.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

Read more
31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

Read more
26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

Read more
23 Jan 2015 13:36

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Read more
21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

Read more
16 Oct 2014 07:40

E-Therapeutics Appoints Sean Nicholson As Executive Director

Read more
16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

Read more
4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

Read more
25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

Read more
12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

Read more
8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

Read more
8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.